Friday, March 20, 2009

Chicken Futures and BioTech Stocks

UPDATE: Ace tracked down the support docs. Less here than meets the eye--we think...

Hildebeeste shared her knowledge with Dear Leader.

On February 22, 2005, Barack Obama, a U.S. Senator at the time, placed a trade on a tiny biotechnology company out of Oregon. The biotech company's name is AVI Biopharma.
Records show that Obama purchased tiny AVI Biopharma just above $2 a share.

AVI Biopharma is a biotech that's been around for years. It develops drugs intended for the use to treat infectious diseases... some of which the Department of Homeland Security have deemed "bioterrorism" viruses like West Nile, Dengue fever, SARS and Ebola

8 months after Obama bought the stock, the company was awarded a $28 million contract from the federal government to research treatments against biological warfare or a bioterrorism attack.

AVI Biopharma spiked in price… and days after the announcement, Obama sold his shares and booked a 73% profit.

Just co-incidence.

I recall reading a study (10 years ago??) which demonstrated beyond dispute that US Senators were accumulating net-worth gains at a much greater rate than 'average' US investors.

In some places, that's called "insider trading."

HT: Confederate

No comments: